Results 121 to 130 of about 2,760,769 (327)

Mandibular Osteitis Fibrosa Cystica as First Sign of Vitamin D Deficiency

open access: yesCase Reports in Dentistry, 2018
Introduction. Brown tumors of hyperparathyroidism are locally destructive bone lesions. They are the late clinical consequence of the disease. They can occur in primary, secondary, and rarely tertiary forms.
Nour Mellouli   +5 more
doaj   +1 more source

Targeted Alkaline Phosphatase Therapy Enhances Alveolar Bone Healing in X‐Linked Hypophosphatemia in Mice

open access: yesJournal of Periodontal Research, EarlyView.
Effects of exogenous tissue‐nonspecific alkaline phosphatase (TNAP) were analyzed in the Hyp mouse model of X‐linked hypophosphatemia (XLH). Maxillary first molars were extracted from wild‐type (WT) and Hyp mice at 6 weeks, and collagen gel ± TNAP was placed in sockets. In one group of Hyp mice, submucosal injections of TNAP or saline were delivered at
Aonjittra Phanrungsuwan   +3 more
wiley   +1 more source

Calcitriol in the Management of Secondary Hyperparathyroidism of Renal Failure [PDF]

open access: yes, 1996
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90092/1/j.1875-9114.1996.tb03644.x ...
Daisley‐kydd, Racquel E.   +1 more
core   +1 more source

Differential Diagnosis of Primary and Secondary Hyperparathyroidism Caused by Vitamin D Deficiency

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2015
Causes of secondary increase of parathyroid hormone, especially vitamin D deficiency, can significantly interfere with the diagnosis of hyperparathyroidism.
S.M. Cherenko, H.V. Bandura
doaj   +1 more source

Secondary hyperparathyroidism: Update

open access: yesWorld Journal of Advanced Research and Reviews
Secondary hyperparathyroidism is a clinical condition characterized by an increase in the synthesis and secretion of parathyroid hormone (PTH). Its presentation will be conditioned by the development of stimuli such as hyperphosphatemia, hypocalcemia, vitamin D deficiency, and PTH resistance.
Erick Alexander Cabrera Estrada   +9 more
openaire   +1 more source

Secondary and Tertiary Hyperparathyroidism in Chronic Kidney Disease: An Endocrine and Renal Perspective

open access: yesIndian journal of endocrinology and metabolism, 2019
Secondary Hyperparathyroidism (SHP) seen as a frequent complication in Chronic Kidney Disease (CKD) has many pathogenetic peculiarities that are still incompletely defined and understood.
M. Chandran, Jiunn Wong
semanticscholar   +1 more source

Weekly biological variation of serum biochemistry analytes and fibroblast growth factor 23 in healthy cats and cats with chronic kidney disease

open access: yesJournal of Small Animal Practice, EarlyView.
Objective The objective of the study was to determine the biological variation of select serum biochemistry analytes and fibroblast growth factor 23 in both clinically healthy cats and cats with chronic kidney disease. Methods Eleven healthy cats and seven cats with chronic kidney disease International Renal Interest Society Stages 2 and 3 were ...
S. Summers   +3 more
wiley   +1 more source

Concurrent papillary thyroid cancer and parathyroid adenoma as a rare condition: A case report [PDF]

open access: yes, 2012
Although the pathological relationship between parathyroid and thyroid diseases is common, an association between parathyroid adenoma and thyroid cancer is rare.
Assadi, M.   +8 more
core   +1 more source

Experience of surgical treatment of secondary hyperparathyroidism

open access: yesActa Biomedica Scientifica, 2016
Surgical treatment of secondary hyperparathyroidism (HPT) in patients having renal replacement therapy (RRT) is a current problem. The aim of our study was to optimize the treatment of secondary HPT based on the comparative analysis of effectiveness of ...
E. A. Ilyicheva   +5 more
doaj   +1 more source

Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease [PDF]

open access: yes, 2016
Secondary hyperparathyroidism (SHPT) is a common complication of CKD and is part of the chronic kidney disease-mineral bone disorder (CKD-MBD). SHPT is associated with increased risk of fracture and mortality, thus SHPT control is recommended as kidney ...
Khwaja, A., Salam, S.N., Wilkie, M.E.
core   +1 more source

Home - About - Disclaimer - Privacy